Catalent
CTLT
#1572
Rank
โ‚น909.35 B
Marketcap
โ‚น5,010
Share price
0.74%
Change (1 day)
69.92%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚น417.62 Billion

According to Catalent's latest financial reports the company's total debt is โ‚น417.62 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30โ‚น398.88 B19.92%
2022-06-30โ‚น332.63 B37.48%
2021-06-30โ‚น241.95 B5.38%
2020-06-30โ‚น229.59 B12.52%
2019-06-30โ‚น204.04 B9.55%
2018-06-30โ‚น186.25 B38.24%
2017-06-30โ‚น134.73 B7.42%
2016-06-30โ‚น125.42 B4.65%
2015-06-30โ‚น119.85 B-26.35%
2014-06-30โ‚น162.73 B1.56%
2013-06-30โ‚น160.24 B7.57%
2012-06-30โ‚น148.96 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น3.22 B-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น28.44 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น523.57 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น18.89 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA